Navigation Links
Healthpoint Biotherapeutics to Present at 30th Annual J.P. Morgan Healthcare Conference
Date:1/5/2012

FORT WORTH, Texas, Jan. 5, 2012 /PRNewswire/ -- Healthpoint Biotherapeutics today announced that Travis E. Baugh, President and Chief Operating Officer, and Robert Bancroft, Executive Vice President, Strategic and Commercial Development, will present an overview of the Company, its commercial products and its R&D pipeline at the upcoming J.P. Morgan Healthcare Conference. The presentation is scheduled for Tuesday, January 9th, at 9:30 am (PST) at the Westin St. Francis Hotel in San Francisco, CA.

The presentation will include updates on the Company's ongoing commercial operations and phase 3 plans for its cell therapy pipeline candidate for venous leg ulcers (HP802-247).

About Healthpoint Biotherapeutics

Healthpoint Biotherapeutics is a biopharmaceutical company focused on the development and commercialization of novel, cost-effective solutions for dermal repair and regeneration. The company's research and development strategy is presently centered around next-generation cell-based therapies for the treatment of chronic wounds. Currently marketed products include Collagenase SANTYL® Ointment, OASIS® Wound Matrix, OASIS® Ultra Tri-Layer Matrix and REGRANEX® Gel. Healthpoint Biotherapeutics is also committed to advancing the care and treatment of wounds through support of industry leading continuing education from The Wound Institute®. To learn more about this comprehensive and award winning educational resource, please visit TheWoundInstitute.com®. Healthpoint Biotherapeutics is a DFB Pharmaceuticals, Inc., affiliate company, and is based in Fort Worth, Texas. For more information, visit the company website at www.Healthpointbio.com.

HEALTHPOINT, SANTYL, THE WOUND INSTITUTE, THEWOUNDINSTITUTE.COM and REGRANEX are registered trademarks of Healthpoint, Ltd.

OASIS is a registered trademark of Cook Biotech, Inc.

 


'/>"/>
SOURCE Healthpoint Biotherapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Healthpoint Biotherapeutics to Present at UBS Global Life Sciences Conference
2. Healthpoint Biotherapeutics Acquires Regranex® Gel
3. CMC Biologics Licenses Its CHEF1® Expression System to Oxford BioTherapeutics
4. Family Foundation of Business Leader Invests $4.55 Million in Northwest Biotherapeutics for Promising Clinical Trials in the US and Europe
5. Northwest Biotherapeutics Announces Change and Expansion of Management Team
6. Northwest Biotherapeutics Announces Series of Financing Arrangements
7. Northwest Biotherapeutics to Present at American Society of Cell and Gene Therapy
8. Northwest Biotherapeutics and the Fraunhofer Institute for Cell Therapy and Immunology are Partnering for Clinical Trials and Compassionate Use Cases in Europe
9. Talecris Biotherapeutics Announces Results of Annual Stockholders Meeting
10. Talecris Biotherapeutics Announces First Quarter 2011 Results
11. Talecris Biotherapeutics to Report First Quarter 2011 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/14/2017)... ... June 13, 2017 , ... ... understanding the phenotype of an organism on a molecular level that is ... data processing remain major bottlenecks to biomarker discovery in clinical-based metabolomics research. ...
(Date:6/13/2017)... ... June 13, 2017 , ... ... chosen The Copley Consulting Group to facilitate and deploy Infor’s CloudSuite Industrial ... manufacturing operations and strategic initiatives to increasing customer demands. , “The clients ...
(Date:6/13/2017)... Va. (PRWEB) , ... June 13, 2017 , ... ... Ph.D. will keynote the American Chemical Society (ACS) Green Chemistry Institute’s ... at 8:45 a.m. EST. Dr. Feehery will address other business leaders, policy makers, ...
(Date:6/12/2017)... , ... June 12, 2017 , ... ... safety analytics products and services, today announced that Paul Barrow has joined the ... helping to optimize their signal detection processes and methodologies by leveraging capabilities in ...
Breaking Biology Technology:
(Date:4/5/2017)... , April 5, 2017  The Allen Institute for ... Cell Explorer: a one-of-a-kind portal and dynamic digital window ... imaging data, the first application of deep learning to ... stem cell lines and a growing suite of powerful ... for these and future publicly available resources created and ...
(Date:3/30/2017)... -- On April 6-7, 2017, Sequencing.com will host the world,s ... at Microsoft,s headquarters in Redmond, Washington ... health and wellness apps that provide a unique, personalized ... is the first hackathon for personal genomics and the ... the genomics, tech and health industries are sending teams ...
(Date:3/27/2017)... N.Y. , March 27, 2017  Catholic ... Information and Management Systems Society (HIMSS) Analytics for ... EMR Adoption Model sm . In addition, CHS ... of U.S. hospitals using an electronic medical record ... for its high level of EMR usage in ...
Breaking Biology News(10 mins):